Cognitive Training After Stroke : Effects and Mechanisms
Kognitiv Trening Etter Hjerneslag: Effekter og Mekanismer #2015/1282
Stroke is a major cause of severe cognitive and physical disability. Despite the high and increasing incidence, and large health, economic, social and personal consequences, studies designed to remedy cognitive impairments and improve rehabilitation care following stroke are lacking. A promising line of research have shown that weak electrical current (tDCS) can be a safe, cost-effective, and potent treatment when combined with other rehablitational approaches.
The underlying mechanism is assumed that tDCS facilitates neuronal signaling, improving plasticity and facilitating rehablitational outcome. But further research is needed to better understand the mechanisms at hand, and to better evaluate the potential clinical utility.
The scope for the current project is to investigate both cognitive and neuronal effects of tDCS in combination with cognitive training , with the ultimate goal to improve current rehabilitational healthcare. To achieve this we will use multimodal MRI, EEG, and a comprehensive battery of neuropsychological asessment, to describe and evaluate the effect of tDCS in rehabilitation purposes.
Visão geral do estudo
Status
Condições
Descrição detalhada
Participants are randomly assigned to either active or sham condition, using codes provided by the manufacturer and implemented by an in-house Matlab script, pseudo-randomizing participants while maintaining balance in groups of 20. tDCS stimulation is applied at six occasions for each participant, with a minimum of 48 hours between stimulations, aiming at an average of two stimulations per week. Stimulation current is1000 μA, stimulation time was 20 min for the active group with a ramp-up time of 120 s and fade-out time of 30 s. The current intensity is limited to 1 mA to limit the risk of adverse events due to the electrical stimulation. The sham stimulation consists of ramp-up followed by 40 s of active stimulation and then fade-out, following factory settings.
Cognitive training will be done by the computerized working memory training program (Cogmed Systems AB, Stockholm, Sweden) consisting of 25 online training sessions. In this study, to increase feasibility, we utilize 17 sessions over a period of three to four weeks, corresponding to approximately five weekly training sessions. On average, we aim at two training sessions combined with tDCS per week with a minimum of one day between each tDCS session. The remaining CCT sessions are performed at home.
Neuropsychological assessments and MRI assessments are conducted three times: at baseline 1, after a waiting period of 2-4 weeks (baseline 2, before intervention) and immediately post intervention. Self-reported symptoms of fatigue and depression are assessed at five time points, before, during and after completing intervention.
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
-
Oslo, Noruega
- Oslo University Hospital
-
Oslo, Noruega
- Oslo University hospital Ullevål
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- MR/CT revealing ischemic or hemorrhagic damage (stroke).
Exclusion Criteria:
- History of illness or damage to the CNS, besides stroke.
- <18 years of age
- Extensive cognitive decline or dementia
- Severe psychiatric disorders
- Substance or alcohol abuse
- Contraindications for MRI.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Triplo
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Comparador Ativo: Active stimulation
Participants recieving active trancranial direct current stimulation (tDCS) Parameters: 20 minutes anodal tDCS 1mA.
Two times a week, for three weeks.
Anode placed at F3, cathode placed at right cerebellum.
|
|
|
Comparador de Placebo: Sham stimulation
Participants recieving passive / sham trancranial direct current stimulation (tDCS) Two times a week, for three weeks.
Anode placed at F3, cathode placed at right cerebellum.
|
Sham Transcranial direct current stimulation (tDCS)
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Evidence of change in neural activity in attentional-related brain areas after receiving anodal tDCS, as measured with functional MRI
Prazo: One and a half year
|
Change in activation patterns during multiple object tracking (MOT) at first baseline, before initiating training (second baseline, on average 4 weeks after baseline measure), and after a three-week intervention (post-intervention assessment)
|
One and a half year
|
|
Evidence of structural changes after receiving anodal tDCS, as measured with structural MRI
Prazo: One and a half year
|
Structural MRI
|
One and a half year
|
|
Evidence of increased attentional and working memory capacity after receiving anodal tDCS
Prazo: One and a half year
|
Rate of improvement in Cogmed tasks
|
One and a half year
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Evidence of increased attentional capacity after receiving anodal tDCS
Prazo: One and a half year
|
Performance change in The Theory of Visual Attention (TVA) computerized paradigm.
|
One and a half year
|
Outras medidas de resultado
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Evidence of change in fatigue severity after receiving tDCS
Prazo: One and a half year
|
Fatigue Severity Scale (FSS), a seven-point Likert scale on subjective fatigue severity/impact.
9 items scored from 1 (less symptoms) to 7 (most severe symptoms).
Scores are reported as mean scores, lowest possible mean = 1, highest possible mean = 7.
|
One and a half year
|
|
Evidence of change in symptoms of depression after receiving tDCS
Prazo: One and a half year
|
Patient Health Questionnaire (PHQ-9), self-reported depressive symptoms.
Scale consists of 9 items, scored from 0 (not at all) to 3 (nearly every day).
Scores are reported as sum scores, range 0 (less symptoms) - 27 (more symptoms)
|
One and a half year
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Diretor de estudo: Lars T. Westlye, Ph.D, University of Oslo
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- 2015/1282
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .